Clinical aspects and risks of the phenol/croton oil.

acne scars croton oil deep chemical peeling keratosis phenol skin aging wrinkles

Journal

Experimental and therapeutic medicine
ISSN: 1792-1015
Titre abrégé: Exp Ther Med
Pays: Greece
ID NLM: 101531947

Informations de publication

Date de publication:
Nov 2024
Historique:
received: 19 03 2024
accepted: 03 07 2024
medline: 20 9 2024
pubmed: 20 9 2024
entrez: 20 9 2024
Statut: epublish

Résumé

Phenol/croton oil is a unique chemical formulation promoting deep skin resurfacing and cellular renovation. Even though it has been used for decades in plastic surgery, the clinicopathological features, as well as the risks related to phenol/croton oil clinical application have not been thoroughly studied. The aim of the present study was to assess the effectiveness of the phenol/croton oil peel, the pathological characteristics from 1 patient at least and the emerging potential risks. A total of 64 patients were treated with phenol/croton oil peel between 2014 and 2023; in total, 21 of them underwent resurfacing at their oral area (upper/lower lips), 15 underwent resurfacing at their lower eyelid wrinkles, 22 patients underwent full face resurfacing, 2 patients were treated for their acne scars and additionally 4 patients were treated for multiple body seborrheic keratosis. The wrinkles, as well as the acne scars were markedly improved in all patients, the seborrheic keratosis was eliminated, while adverse events and undesired clinical manifestations related to peel intervention were mild and reversible for all patients. The application of phenol/croton oil constitutes an immensely powerful tool for deep chemical peeling and facial skin rejuvenation; nevertheless, it should be used cautiously due to its potential complications.

Identifiants

pubmed: 39301260
doi: 10.3892/etm.2024.12711
pii: ETM-28-5-12711
pmc: PMC11412097
doi:

Types de publication

Journal Article

Langues

eng

Pagination

422

Informations de copyright

Copyright © 2024, Spandidos Publications.

Déclaration de conflit d'intérêts

The authors declare that they have no competing interests.

Auteurs

Ioannis E Liapakis (IE)

Opsis Clinical Plastic and Reconstructive Surgery, 71304 Heraklion, Greece.

Georgios K Ismailos (GK)

Experimental Research Center ELPEN, ELPEN Pharmaceuticals, 19009 Pikermi, Greece.

Angelos Michail (A)

Michail Clinic for Plastic and Reconstructive Surgery, 5961 BH Maastricht, The Netherlands.

Georgios P Tsakonis (GP)

Tsakonis Plastic and Reconstructive Surgery Clinic, 12134 Athens, Greece.

Georgia Gloustianou (G)

Histopathologic Diagnosis, 11521 Athens, Greece.

Ioannis Koliarakis (I)

School of Medicine, University of Crete, 71500 Heraklion, Greece.

Apostolos D Mandrekas (AD)

Artion Plastic Surgery Center, 15451 Athens, Greece.

Classifications MeSH